Leronlimab Shows Inhibits Colon Carcinoma Metastases to Liver & Lung in Preclinical Studies: Can the Sponsor Finance Clinicals?

Leronlimab Shows Inhibits Colon Carcinoma Metastases to Liver & Lung in Preclinical Studies: Can the Sponsor Finance Clinicals?

CytoDyn’s PRO 140, a CCR5 antagonist called leronlimab, inhibited a human colon carcinoma cell line, SW480, metastases to liver and lung in a well-accepted mouse model in pre-clinical research phase. Cytodyn, a small emerging biotech, was recently cleared by the FDA...
2018 Global BioPharma IP Law Round Up

2018 Global BioPharma IP Law Round Up

TrialSite News completes the year with excitement. Founded as a simple and straightforward site to contribute to the cause of transparency in clinical research with a focus on the research site/center, the news site turns six months old on New Year’s Day. The...

Pin It on Pinterest